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Sir,
Borrelia burgdorferi, the causative agent of Lyme disease, infects humans through Ixodes tick bites. In Europe,
several Borrelia strains have been associated with primary cutaneous B-cell lymphoma, in particular, cutaneous
marginal zone B-cell lymphoma.[1] It has already been reported that clinical regression of B. burgdorferi-
associated cutaneous marginal zone B-cell lymphomas did not occur after specific antimicrobial therapy
although polymerase chain reaction (PCR) analysis for Borrelia became negative.[2] Persistence of the
lymphoma could be related to host factors or another unknown antigenic stimulation unresponsive to
antimicrobial treatment. Significant co-infections in Lyme disease could be due to microorganisms transmitted
by the same vector. In our province, (Trieste, North-Eastern Italy) co-infection of Borrelia with Anaplasma
phagocytophilum and Rickettsia helvetica is rather frequent: 15 (3.5%) patients tested positive to Borrelia and
A. phagocytophilum during 2013. To further investigate this association, we carried out a study investigating
the presence of co-infections in patients with proven Borrelia-related cutaneous marginal zone B-cell
lymphoma.
We report on four consecutive patients with the morphological features of primary cutaneous marginal zone B-
cell lymphoma.
The first three patients participating in this study had previously been reported.[3] Patients were investigated
for the presence of B. burgdorferi, A. phagocytophilum and R. helvetica with conventional serology and for
Borrelia also by PCR.[3]
A 62-year-old man presented with cutaneous marginal zone B-cell lymphoma characterized by pink, non-
tender, pruritic skin nodules on his right inner thigh [Figure 1]. Biopsy showed a nodular lymphoid proliferation
of small lymphocytes within the dermis. Clonality of B lymphocytes was revealed by Ki67 staining. Both
serologic tests (ELISA IgG and Western blot) and PCR assays for B. burgdorferi were positive. Serologic
analysis for IgG antibodies to A. phagocytophilum was positive while the test was negative for R. helvetica.
{Figure 1}
A 46-year-old woman presented with five itchy erythematous, non-tender and painless papules on her right leg
[Figure 1]. Routine laboratory investigations were normal. Biopsy of the lesion showed a dense nodular
infiltrate of lymphocytes separated from the epidermis by a Grenz zone [Figure 2].{Figure 2}
B-cell clonality was assessed by lambda and kappa light chain immunohistochemistry in frozen sections [Figure
2]. In view of these findings and the immunophenotype, a diagnosis of cutaneous marginal zone B-cell
lymphoma was made.
Polymerase chain reaction assays for Borrelia DNA were positive both from biopsy and peripheral blood [Figure
2]. Serological investigations for B. burgdorferi and R. helvetica were negative while A. phagocytophilum
serology proved to be IgG positive.
A healthy 35-year-old man developed an infiltrated erythematous patch on his right leg [Figure 1]. The patient
had a previous history of Lyme disease.[3] Skin biopsy showed a top-heavy atypical lymphocytic infiltration
involving the dermis and infiltrating the upper portion of subcutaneous fat. The characteristic Grenz zone of
normal collagen was evident.
Polymerase chain reaction assays for Borrelia DNA were positive both from biopsy and peripheral blood.
Serology for Borrelia was negative, but it was positive for A. phagocytophilum and R. helvetica.
A 36-year-old man developed a nodular erythematous lesion on his back [Figure 1] which was excised and a
diagnosis of marginal cell lymphoma was made. Later, five small nodular lesions appeared around the surgical
scar. Results of routine laboratory examinations were normal. The biopsy showed a top-heavy atypical
lymphocytic infiltration with a Grenz zone.
Polymerase chain reaction assays for Borrelia DNA were positive both from peripheral blood and biopsy.
Serology for Borrelia and A. phagocytophilum was positive, but negative for R. helvetica.
All four patients underwent antibiotic treatment with doxycycline, 100 mg twice a day for 20 days. Lymphomas
were treated in all patients with electrochemotherapy as already reported.[3] A complete response was
obtained in all patients after 4 weeks. During the follow-up period, three patients relapsed as reported in
[Table 1].{Table 1}
The association between chronic infection with Borrelia and the development of cutaneous marginal zone B-cell
lymphoma is conceptually and clinically similar to the one seen in B-cell lymphomas of the stomach, a
proportion of which are associated with infection by Helicobacter pylori. Similarly, the suspected
pathophysiology for the induction of lymphoma by Borrelia is chronic antigen-dependent immunostimulation
triggering sustained lymphoid proliferation with oligoclonal and ultimately monoclonal B-cell selection.[4] It
has been hypothesized that H. pylori eradication leads to the disappearance of intratumoral H. pylori specific T-
cells and to lymphoma regression.[2] In the same way, complete regression of lymphoma lesions has been
seen after antibiotic treatment for B. burgdorferi.[5]
Patients with Borrelia- related cutaneous marginal zone B-cell lymphoma unresponsive to antibiotic treatment
may be subjected to other chronic antigen stimulation.[1] We focused on A. phagocytophilum and R. helvetica
co-infections which are the most frequent microorganisms co-infected with B. burgdorferi by Ixodes ricinus in
our area. We were unable to find any previous reports of the association between primary cutaneous B-cell
lymphoma and other infections concurrent with Borrelia. Our data show that co-infections occur in some
patients with Borrelia-related lymphomas. The impact of concurrent infections in Lyme disease has not yet
been fully clarified because multiple infections are difficult to analyse as it is usually impossible to establish the
infection that plays a predominant role in the pathological process due to frequent overlapping of clinical
symptoms caused by borreliosis and co-infections. We speculate that in case of Borrelia- related primary
cutaneous B-cell lymphoma, multiple infections may influence the immune system by decreasing co-
surveillance and favoring a chronic B-cell stimulation towards an oligo/monoclonal B-cell proliferation. This
may result in resistance to antibiotic therapy or in a persisting and self-maintaining disease driven by unknown
antigenic stimulation even after the eradication of bacteria.
Our study had limitations due to lack of facility to detect A. phagocytophilum in tissue biopsy to demonstrate
the co-infection and that Borrelia infection was not confirmed by serology in two patients. Nevertheless, to
strengthen our data, three distinct PCR analyses have been carried out for Borrelia in both blood and biopsies
for all patients. We were also limited by our small sample size and single geographic area. However, our study
stresses on performing more comprehensive analyses in order to establish if A. phagocytophilum should
always be included in the serologic testing of patients with a history of tick bite, in patients with Lyme disease
and B. burgdorferi-related cutaneous marginal zone B-cell lymphoma since co-infection could be more frequent
than so far suspected.
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